HCPCS Level IIdrugActive
J1456
Inj, fosaprepitant (teva)
BETOS: O1E
Effective: 2024-01-01
Description
Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Fosaprepitant
Manufacturer
Actavis Pharma, Inc.
HCPCS Dosage
1 MG
Billing Units
150.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.